Medicure Incorporated (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, announced yesterday that it has named Dr Neil Owens as its new President and Chief Operating Officer, effective 1 July 2019.
Owens will be responsible for implementing the company's strategic plans, and managing day-to-day operations, including the advancement and management of new and existing pharmaceutical products.
Owens has worked at Medicure since 2014, serving most recently as Director, Scientific Affairs. Owens holds a Bachelor of Science and a PhD in Chemistry from the University of Manitoba and has Post Doctoral experience with the IECB.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign